Literature DB >> 7086528

Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy.

W H Beierwaltes, R H Nishiyama, N W Thompson, J E Copp, A Kubo.   

Abstract

Between 1947 and 1980, 103 patients with well-differentiated thyroid carcinoma with metastases outside the neck were treated with sodium iodide (I-131) after surgical treatment. Forty-one patients had distant metastases first detected an average of 7.44 yr after the initial operation establishing the diagnosis of thyroid carcinoma. Follicular and papillary carcinomas gave the same survival time in patients, matched for age and sex, who had metastases outside the neck. Those considered to be free of their metastatic disease after I-131 therapy survived three times as long as those with persistent disease. Patients freed of their metastases had a higher conformity rate with half of our ten procedures of "ideal" treatment, compared with patients not freed of their metastases.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7086528

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  24 in total

1.  Locally advanced asymptomatic papillary thyroid cancer presenting with retropharyngeal lymph node metastasis symptoms.

Authors:  Roostam Kholmatov; Obinwanne Emejulu; Fadi Murad; Rizwan Aslam; Emad Kandil
Journal:  Gland Surg       Date:  2017-12

Review 2.  Targeted radiotherapy for neuroblastoma.

Authors:  S Meller
Journal:  Arch Dis Child       Date:  1997-11       Impact factor: 3.791

3.  When is total thyroidectomy indicated as a treatment of "follicular carcinoma"?

Authors:  T Yamashita; Y Fujimoto; T Kodama; A Hirayama; T Obara; Y Ito; M Aiba; K Kusakabe
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

4.  The value of intraoperative scintigraphy as a routine procedure in thyroid carcinoma.

Authors:  S Lennquist; J Persliden; S Smeds
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

5.  Intraoperative scintigraphy in surgical treatment of thyroid carcinoma: evaluation of a new technique.

Authors:  S Lennquist; J Persliden; S Smeds
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

Review 6.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

7.  Guidelines for radioiodine therapy of differentiated thyroid cancer.

Authors:  M Luster; S E Clarke; M Dietlein; M Lassmann; P Lind; W J G Oyen; J Tennvall; E Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10       Impact factor: 9.236

8.  Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience.

Authors:  G Mazziotti; A M Formenti; M B Panarotto; E Arvat; A Chiti; A Cuocolo; M E Dottorini; C Durante; L Agate; S Filetti; F Felicetti; A Filice; L Pace; T Pellegrino; M Rodari; M Salvatori; C Tranfaglia; A Versari; D Viola; S Frara; A Berruti; A Giustina; R Giubbini
Journal:  Endocrine       Date:  2017-11-06       Impact factor: 3.633

9.  Metastatic thyroid carcinoma of the adrenal gland.

Authors:  M E Girelli; D Casara; D Rubello; M Piccolo; A Piotto; M R Pelizzo; B Busnardo
Journal:  J Endocrinol Invest       Date:  1993-02       Impact factor: 4.256

10.  Natural history of small radioiodine-avid bone metastases that have no structural correlate on imaging studies.

Authors:  Eyal Robenshtok; Azeez Farooki; Ravinder K Grewal; R Michael Tuttle
Journal:  Endocrine       Date:  2013-12-24       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.